Sandbox carlos: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 12: Line 12:


:*'''HIV'''<ref name=Regimen HIV patients - Cystoisosporiasis>{{cite web | title =AIDSinfoNIH - Cystoisosporiasis| url =http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref>
:*'''HIV'''<ref name=Regimen HIV patients - Cystoisosporiasis>{{cite web | title =AIDSinfoNIH - Cystoisosporiasis| url =http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref>
::*'''Patients with CD4 Count <200/mm3 (chronic treatment)'''
::*'''1. Patients with CD4 Count <200/mm3 (chronic treatment)'''
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly  
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly  
::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly  
::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly  

Revision as of 16:34, 16 July 2015


  • Immunocompetent
  • 1. Patients with sulfa intolerance
  • Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
  • Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days


  • HIV


References